Delivery Order SPE2DX22D0079-SPE2D826FAAF5
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 6, 2025. This firm fixed-price delivery order, valued at $27,760.32 with an ultimate completion date of September 8, 2025, was awarded on a competitive basis without set-aside designations. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 10, 2025. This firm fixed-price delivery order, valued at $10,097.14, is scheduled for completion by September 11, 2025, and represents a competitive award with no set-aside designation. As a child contract under AmerisourceBergen's larger relationship with DLA, this delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $29,247.48 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This non-set-aside, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $51,016.44 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract represents a child award under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $21,168 to AmerisourceBergen Drug Corp on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement running through December 2026. The contract involves pharmaceutical and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,004.72 delivery order to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The award was competitively made with no set-aside designation, and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at approximately $42,000 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This is a firm fixed-price, non-competitive delivery order issued under a competitive contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,746.48 delivery order to AmerisourceBergen Drug Corp on April 29, 2025, with completion targeted for April 30, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract supports federal pharmaceutical and medical supply...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $28,224.74 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D826FAAF5Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on October 20, 2025. This firm fixed-price delivery order, valued at $22,519.18, was competitively awarded with no set-aside designation and is due for completion by October 21, 2025. The award is part of a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at nearly $1 billion through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to federal military and veteran healthcare systems globally. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its extensive capability to fulfill diverse medical procurement requirements, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company supplies critical medical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order represents one of numerous competitively awarded transactions reflecting the company's established track record of meeting federal medical supply standards, with contract values historically ranging from under $100 to over $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 10/20/25 |